Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-12-08 | 2024-01-05 | 212952 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2024-01-12 | 2024-01-19 | 215976 |
| APO-SOTALOL - TAB 160MG | 160MG | TABLET | Resolved | 2017-10-12 | 2018-01-19 | 25636 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2017-09-04 | 2018-01-19 | 20906 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2022-05-06 | 2022-07-15 | 160141 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2020-11-19 | 2021-02-09 | 128626 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2018-07-04 | 2018-07-13 | 54187 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2017-09-06 | 2018-09-11 | 21096 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2020-01-22 | 2020-03-09 | 103923 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Actual shortage | 2025-02-06 | 2025-02-06 | 249763 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2022-09-09 | 2023-09-22 | 169045 |
| APO-SULFATRIM ORAL SUSPENSION | 40MG 8MG | SUSPENSION | Actual shortage | 2017-08-13 | 2017-10-05 | 18991 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2017-06-28 | 2017-08-30 | 14247 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-10-08 | 2021-12-22 | 146913 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2018-04-02 | 2018-11-02 | 44517 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2018-04-10 | 2018-11-03 | 45350 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-01-18 | 2021-02-05 | 131889 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-07-21 | 2023-09-15 | 199539 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-12-01 | 2023-12-15 | 212380 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221732 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |